Rao N. V. S. Mamidi
Oregon Health & Science University(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, PARP inhibition in cancer therapy, Inflammatory mediators and NSAID effects, Pancreatic function and diabetes
Most-Cited Works
- → Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents(2001)88 cited
- → Novel Euglycemic and Hypolipidemic Agents. 1(1998)79 cited
- → Cell-based models to study hepatic drug metabolism and enzyme induction in humans(2005)79 cited
- → Synthesis of Conformationally Constrained Analogues of Linezolid: Structure−Activity Relationship (SAR) Studies on Selected Novel Tricyclic Oxazolidinones(2002)69 cited
- → Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans(2014)63 cited
- → Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives(2002)58 cited
- → Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin(2014)54 cited
- → Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14C-bortezomib(2007)54 cited
- → IVIG Adverse Reactions: Potential Role of Cytokines and Vasoactive Substances(1998)54 cited
- → In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans(2015)53 cited